The notes were converted at 5.625p a share, versus a current share price of 5.15p..
Finance house Yorkville has elected to convert a further portion of tranche 1 of the convertible loan facility it provides to ().
Yorkville converted US$150,000 of tranche 1 convertible loan notes, plus accrued interest of US$15,840, into 2.39mln shares at a conversion price of 5.625p per share.
Shares of the cancer treatments developer currently trade at around 5.15p, having fallen from 5.37p on news of the conversion.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of ValiRx PLC named herein, including the promotion by the Company of ValiRx PLC in any Content on the Site, the Company receives from said issuer...
FOR OUR FULL DISCLAIMER CLICK HERE